After a more than two-year wait, the U.S. Food and Drug Administration today issued its final guidance on mobile medical applications, according to an announcement from the regulatory agency. Going forward, the FDA states that it will take a “tailored approach” to mobile medical apps that “supports innovation while protecting consumer safety.”

read more

Source: FDA final mobile medical app guidance mirrors 2011 draft